Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
SIMVASTATIN
美商默沙東藥廠股份有限公司台灣分公司 台北市信義區信義路五段106號12樓 (86683720)
C10AA01
膜衣錠
SIMVASTATIN (2406002900) 80MG
鋁箔盒裝
製 劑
須由醫師處方使用
MERCK SHARP & DOHME LTD. SHOTTON LANE, CRAMLINGTON, NORTHUMBERLAND, NE23 3JU, UNITED KINDOMHERTFORD ROAD HODDESDON HERFFORDSHIRE EN11 9BU UNITED KINGDOM GB
simvastatin
高膽固醇血症、高三酸甘油酯血症,降低冠心病高危險群或冠心病患者的心血管事件發生率及冠心病致死率、患有異核質家族性高膽固醇血症的兒童病患。
註銷日期: 2013/10/09; 註銷理由: 自請註銷; 有效日期: 2016/03/20; 英文品名: ZOCOR 80MG F.C. TABLETS
已註銷
2001-03-20
PROFILE: ASG-LRF-200x280 CONSTRUCTION: Continuous Printed Sheet. Electronically Counted as Wound onto Core. GRAIN DIRECTION: Machine (Long Grain) ROLL OUTSIDE DIAMETER: 300mm = Minimum; 550mm = Maximum COMMENTS: No Smudges or Show-through Permissible on Reg. Mark Corridor. UNWIND DIRECTION: EDGE CODE: MATERIAL GROUP: PRINTER: Black DISCLAIMER: Schawk Australia has quality checked this artwork and information for complete accuracy. Ownership of the final approval for content, layout, text and spelling is the client’s responsibility. Please review all areas for inaccuracies, omissions or errors before committing to final approval. PR PROPRIETARY P1 P2 N/A 03-JUL-13-v02 119703A02 123 (Sample) N/A RF1 (See Register: REG499) N/A P185 素果 ® 20公絲膜衣錠,40公絲膜衣錠, 80公絲膜衣錠 ZOCOR ® 20 MG F.C. TABLET, 40 MG F.C. TABLET, 80 MG F.C. TABLET (SIMVASTATIN, MSD) PC-MK0733-T-102012 20公絲 衛署藥輸字第020037號 0733-TWN-2013-007275 40公絲 衛署藥輸字第023506號 80公絲 衛署藥輸字第 023144號 本藥須由醫師處方使用 ZOCOR ® (simvastatin, MSD)為降膽固醇劑,由土麴菌 (Aspergillus terreus) 之發酵產物合成而得。 ZOCOR為無活性之內酯,口服後水解為其β-氫氧酸型式;此為其主 代謝物,且為3-hydroxy-3-methylglutaryl-coenzyme A, HMG-CoA還 原酵素之抑制劑;此酵素負責催化膽固醇生合成之早期步驟,其亦為 速率決定步驟。依臨床研究顯示ZOCOR對異型接合子(heterozygous) 家族性及非家族性高膽固醇血症,混合型高血脂症病患其膽固醇 過高且單獨以飲食控制效果不佳者,可有效降低其總血漿膽固醇 (total plasma cholesterol; total-C)、低密度脂蛋白膽固醇(low-density lipoprotein cholesterol; LDL-C)、三酸甘油酯(triglycerides; TG)及極低 密度脂蛋白膽固醇(very-low-density lipoprotein cholesterol; VLDL-C) 並升高高密度脂蛋白膽固醇(HDL-C)濃度。以ZOCOR治療,二週內 即可得到顯著療效,四至六週後即達最佳 Read the complete document